Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era

Imagem de Miniatura
Arquivos
art_TAKEDA_Predictive_factors_of_recurrence_in_adenocarcinoma_of_the_2021.PDF (386.2 KB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Autores
Citação
AMERICAN JOURNAL OF SURGERY, v.221, n.3, p.631-636, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Adenocarcinoma of the esophagogastric junction (AEGJ) represents a poor prognostic tumor. We evaluated the recurrence pattern and risk factors associated with recurrence in patients undergoing surgical resection by AEJG. Methods: Recurrences were categorized as locoregional, peritoneal, or distant. These three recurrence groups and a non-recurrence group were compared, and overall survival (OS) and disease-free survival (DFS) for each one was obtained. Results: We analyzed 188 patients with curative surgical treatment. Recurrence was observed in 72 (38.3%) patients. Locoregional recurrence was observed in 17 (23.6%); 20 (27.8%) peritoneal recurrence and 35 (48.6%) distant metastasis. DFS was 9, 5, and 8 months, and OS was 21.8, 13.2, and 20.8, respectively. Tumors larger than 5 cm are risk factors for peritoneal recurrence (OR:2.88, p = 0.012). Positive lymph nodes were related to distant metastasis (OR:9.15, p = 0.040), and lymphatic invasion for locoregional recurrence (OR:3.81, p = 0.028). Conclusion: AEGJ is associated with high rates of early recurrence.
Palavras-chave
Esophagogastric junction, Recurrence, Survival, Prognosis, Metastasis
URI
https://observatorio.fm.usp.br/handle/OPI/40662
Referências
  1. Abate E, 2010, J AM COLL SURGEONS, V210, P428, DOI 10.1016/j.jamcollsurg.2010.01.006
  2. Al-Batran SE, 2019, LANCET, V393, P1948, DOI 10.1016/S0140-6736(18)32557-1
  3. Al-Batran SE, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3918-9
  4. Al-Batran SE, JAMA ONCOL
  5. HOLSCHER AH, 1995, SURGERY, V118, P845, DOI 10.1016/S0039-6060(05)80275-2
  6. Hulscher JBF, 2000, J AM COLL SURGEONS, V191, P143, DOI 10.1016/S1072-7515(00)00349-5
  7. Jiang DM, 2020, CANCER MED-US, V9, P3023, DOI 10.1002/cam4.2948
  8. Knight WRC, 2017, BJS OPEN, V1, P182, DOI 10.1002/bjs5.30
  9. Lou FR, 2013, J THORAC ONCOL, V8, P1558, DOI 10.1097/01.JTO.0000437420.38972.fb
  10. Moorcraft SY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2145-0
  11. Sakamaki Y, 2020, GEN THORAC CARDIOVAS, V68, P1172, DOI 10.1007/s11748-020-01368-5
  12. Takeda FR, 2020, ANN SURG ONCOL, V27, P1241, DOI 10.1245/s10434-019-07967-8
  13. Togano S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225958
  14. Tustumi F, 2016, ABCD-ARQ BRAS CIR DI, V29, P138, DOI 10.1590/0102-6720201600030003
  15. van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088
  16. Victor CR, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00103
  17. von Rahden BHA, 2005, J CLIN ONCOL, V23, P874, DOI 10.1200/JCO.2005.12.151
  18. Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - ODS/03